Get the latest tech news
Salva Health wants to lower breast cancer mortality with its affordable screening device
Six years ago, while researching for a college entrepreneurship competition, Valentina Agudelo identified a troubling gap in breast cancer survival rates
She realized that breast cancer is highly treatable when diagnosed early, yet many Latin American countries have large rural populations lacking access to mammograms and other diagnostic tools. Shortly after the competition ended, Agudelo founded Salva Health and began developing the company’s first product, Julietta, a small device that measures tissue density with electrodes that attach to each breast and provides results within minutes to a phone, tablet, or computer. Image Credits: Salva HealthSalva Health partnered with Grupo Sura, a major Colombian insurance company, to conduct clinical trials and develop an AI model capable of predicting breast cancer risk.
Or read this on TechCrunch